Smith, Carolina
Hasselgren, Mikael
Sandelowsky, Hanna
Ställberg, Björn
Hiyoshi, Ayako
Montgomery, Scott
Funding for this research was provided by:
Örebro University
Article History
Received: 12 November 2024
Accepted: 18 February 2025
First Online: 5 March 2025
Declarations
:
: Ethical permission for this study was obtained from the Swedish Ethical Review Authority (2019–04755 and 2023-03585-02). All data are pseudonymised.
: Not applicable.
: Not applicable.
: BS has received honoraria for educational activities and lectures from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis and has served on advisory boards arranged by AstraZeneca, Novartis, GlaxoSmithKline and Boehringer Ingelheim. HS has received honoraria for educational activities and service on advisory boards from ALK, AstraZeneca, Chiesi, GlaxoSmithKline, Orion Pharma, and Sanofi. The authors report no other conflicts of interest in this work.